AbbVie, Inc. (ABBV) is currently at $98.05, up $1.88 or 1.95% 



  -- Would be highest close since Aug. 17, 2018, when it closed at $98.81 


  -- Earlier Wednesday, AbbVie and Genmab A/S said they will jointly develop and commercialize three of Genmab's early-stage investigational bispecific antibody product candidates and form a discovery research collaboration for future differentiated antibody therapeutics for cancer 


  -- Currently up six of the past seven days 


  -- Currently up five consecutive days; up 7.88% over this period 


  -- Longest winning streak since Feb. 12, 2020, when it rose for eight straight trading days 


  -- Best five day stretch since the five days ending May 15, 2020, when it rose 8.04% 


  -- Up 5.81% month-to-date 


  -- Up 10.74% year-to-date 


  -- Down 20.42% from its all-time closing high of $123.21 on Jan. 26, 2018 


  -- Up 24.79% from 52 weeks ago (June 12, 2019), when it closed at $78.57 


  -- Up 55.68% from its 52-week closing low of $62.98 on Aug. 15, 2019 


  -- Traded as high as $98.54; highest intraday level since Aug. 28, 2018, when it hit $98.70 


  -- Up 2.46% at today's intraday high 


  -- Eighth best performer in the S&P 500 today 


  All data as of 10:12:29 AM 


  Source: Dow Jones Market Data, FactSet